| Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS TM Miller, ME Cudkowicz, A Genge, PJ Shaw, G Sobue, RC Bucelli, ... New England Journal of Medicine 387 (12), 1099-1110, 2022 | 681 | 2022 |
| Physical exercise is a risk factor for amyotrophic lateral sclerosis: convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes TH Julian, N Glascow, ADF Barry, T Moll, C Harvey, YC Klimentidis, ... EBioMedicine 68, 2021 | 117 | 2021 |
| Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis S Zhang, J Cooper-Knock, AK Weimer, M Shi, T Moll, JNG Marshall, ... Neuron 110 (6), 992-1008. e11, 2022 | 110 | 2022 |
| A review of Mendelian randomization in amyotrophic lateral sclerosis TH Julian, S Boddy, M Islam, J Kurz, KJ Whittaker, T Moll, C Harvey, ... Brain 145 (3), 832-842, 2022 | 56 | 2022 |
| Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity S Zhang, J Cooper-Knock, AK Weimer, M Shi, L Kozhaya, D Unutmaz, ... Cell systems 13 (8), 598-614. e6, 2022 | 31* | 2022 |
| Advances in the genetic classification of amyotrophic lateral sclerosis J Cooper-Knock, C Harvey, S Zhang, T Moll, IS Timpanaro, KP Kenna, ... Current opinion in neurology 34 (5), 756-764, 2021 | 24 | 2021 |
| Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis S Boddy, M Islam, T Moll, J Kurz, D Burrows, A McGown, A Bhargava, ... Brain Communications 4 (2), fcac069, 2022 | 13 | 2022 |
| Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes. EBioMedicine 68: 103397 TH Julian, N Glascow, ADF Barry, T Moll, C Harvey, YC Klimentidis, ... J. EBIOM 10, 2021 | 11 | 2021 |
| Considerations in the search for epistasis M Balvert, J Cooper-Knock, J Stamp, RP Byrne, S Mourragui, J van Gils, ... Genome Biology 25 (1), 296, 2024 | 8 | 2024 |
| Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis C Harvey, M Weinreich, JAK Lee, AC Shaw, L Ferraiuolo, H Mortiboys, ... Heliyon 10 (3), 2024 | 6* | 2024 |
| Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication T Moll, V Odon, C Harvey, MO Collins, A Peden, J Franklin, E Graves, ... Life Science Alliance 6 (1), 2023 | 4 | 2023 |
| Deep learning modeling of rare noncoding genetic variants in human motor neurons defines CCDC146 as a therapeutic target for ALS S Zhang, T Moll, J Rubin-Sigler, S Tu, S Li, E Yuan, M Liu, A Butt, ... medRxiv, 2024 | 2 | 2024 |
| An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2 KC Demaegd, A Kernan, J Cooper-Knock, JJFA van Vugt, C Harvey, ... European Journal of Human Genetics, 1-7, 2025 | | 2025 |
| Considerations in the search for epistasis (vol 25,296, 2024) M Balvert, J Cooper-Knock, J Stamp, RP Byrne, S Mourragui, J van Gils, ... GENOME BIOLOGY 26 (1), 2025 | | 2025 |
| Author Correction: Considerations in the search for epistasis M Balvert, J Cooper-Knock, J Stamp, RP Byrne, S Mourragui, J van Gils, ... Genome Biology 26, 12, 2025 | | 2025 |
| Evaluation of a biomarker for amyotrophic lateral sclerosis derived from a hypomethylated DNA signature of human motor neurons C Harvey, A Nowak, S Zhang, T Moll, AK Weimer, AM Barcons, ... BMC Medical Genomics 18 (1), 10, 2025 | | 2025 |
| An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2 J Cooper-Knock, K Demaegd, A Kernan, J van Vugt, C Harvey, T Moll, ... | | 2024 |
| predicTTE: An accessible and optimal tool for time-to-event prediction in neurological diseases M Weinreich, H McDonough, N Yacovzada, I Magen, Y Cohen, C Harvey, ... bioRxiv, 2024 | | 2024 |
| Non-coding genome contribution to ALS T Moll, C Harvey, E Alhathli, S Gornall, D O’Brien, J Cooper-Knock International Review of Neurobiology 176, 75-86, 2024 | | 2024 |
| Theme 01-EPIDEMIOLOGY AND INFORMATICS. J Cooper-Knock, S Boddy, M Islam, J Kurz, T Julian, C Harvey, T Moll, ... Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 22, 2021 | | 2021 |
